7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Successful generation of induced pluripotent stem cells entails a major metabolic switch from mitochondrial oxidative phosphorylation to glycolysis during the reprogramming process. The mechanism of this metabolic reprogramming, however, remains elusive. Here, our results suggest that an Atg5-independent autophagic process mediates mitochondrial clearance, a characteristic event involved in the metabolic switch. We found that blocking such autophagy, but not canonical autophagy, inhibits mitochondrial clearance, in turn, preventing iPSC induction. Furthermore, AMPK seems to be upstream of this autophagic pathway and can be targeted by small molecules to modulate mitochondrial clearance during metabolic reprogramming. Our work not only reveals that the Atg5-independent autophagy is crucial for establishing pluripotency, but it also suggests that iPSC generation and tumorigenesis share a similar metabolic switch.

          Related collections

          Author and article information

          Journal
          Nat. Cell Biol.
          Nature cell biology
          1476-4679
          1465-7392
          Nov 2015
          : 17
          : 11
          Affiliations
          [1 ] Gladstone Institute of Cardiovascular Disease, San Francisco, California 94158, USA.
          [2 ] Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California 94158, USA.
          [3 ] Institute of Immunology, PLA, Third Military Medical University, Chongqing 400038, China.
          [4 ] Center for Stem Cell and Regenerative Medicine, Shanghai Advanced Research Institute, Chinese Academy of Sciences, No. 99, Haike Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai 201210, China.
          [5 ] Department of Pharmacology and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, USA.
          Article
          ncb3256
          10.1038/ncb3256
          26502054
          70fec3a0-fa7a-4fe1-84aa-710c1a8826d9
          History

          Comments

          Comment on this article